RE:RE:National Bank On ThOh my, so much has happened since December. Huge disappointment. Huge loss. Very sad.
My opinion: They will put the oncology progra on the back-burner unless they calculate their chances of a successful proof of concept b)75% success rate (that is, get responses either CR or PR in 30% of patients in one indication). He's too conservative to move forward without outside expertise telling him it will work with X% success rate. At one point in time, I think the preclinical data will have to be reproduced by a second lab elsewhere in the world. I don't want to doubt preclinical work, but to have this type of failure seems odd and surely has caused executives to start having doubt. And that's never good.